<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="MedAAEMArchives of Academic Emergency Medicine2645-4904Shahid Beheshti University of Medical SciencesTehran," exact="Iran" post="e45 : Review Article Antiviral therapy in management of"/>
 <result pre="articles were conducted in China, one article was conducted in" exact="South Korea" post="and one study was performed in Singapore. Only one"/>
 <result pre="Combination Main findings Randomized clinical trial Cao et al; 2020;" exact="China" post="(10) 199 58 (50 to 68) 120 Severe COVID-19"/>
 <result pre="lopinavirâ€&quot;ritonavir treated and standard care groups. Case-series Chen N; 2020;" exact="China" post="(11) 99 21 to 82 67 COVID-19 patients Oseltamivir"/>
 <result pre="Yes Recovery rate: 31%; Mortality rate: 11% Chen Q; 2020;" exact="China" post="(12) 9 14 to 56 5 Symptomatic COVID-19 Lopinavir/"/>
 <result pre="hospital stay was 9 to 20 days. Guan W; 2020;" exact="China" post="(13) 1099 47.0 (IQR: 35.0â€&quot;58.0) 637 Non-severe and severe"/>
 <result pre="admission and need for ventilator or death Hu Z; 2020;" exact="China" post="(15) 24 5 to 95 8 Asymptomatic COVID-19 infection"/>
 <result pre="mortality, no ICU admission, no severe complication Huang C; 2020;" exact="China" post="(16) 41 49 (IQR 41Â·0â€&quot;58Â·0) 30 Symptomatic COVID-19 Oseltamivir"/>
 <result pre="6 patients died 28 patients were discharged Liu K; 2020;" exact="China" post="(19) 137 20 to 83 61 Severe COVID-19 Not"/>
 <result pre="Yes 16 patients died during the study. Liu L; 2020;" exact="China" post="(20) 51 16 to 68 32 Discharged COVID-19 patients"/>
 <result pre="stay was 9-13 days. 1 patient died. Qin X; 2020;" exact="China" post="(21) 89 23 to 86 45 All COVID-19 patients"/>
 <result pre="patients were discharged and 1 patient died. Shang J; 2020;" exact="China" post="(22) 416 49 (IQR: 36-61) 194 Survived and dead"/>
 <result pre="(5.6% in non-treated vs. 12.9 treated; p=0.288) Wang D; 2020;" exact="China" post="(23) 138 22 to 92 75 ICU and Non-ICU"/>
 <result pre="and 36 patients were admitted to ICU. Wu J; 2020;" exact="China" post="(25) 80 46.10 Â± 15.42 39 All severity ranges"/>
 <result pre="discharged and 59 patients remained in hospital. Xu X; 2020;" exact="China" post="(26) 62 41 (IQR: 32-52) 35 Symptomatic COVID-19 Lopinavir/ritonavirArbidolLopinavir/ritonavir"/>
 <result pre="was discharged. Other patients remained in hospital Yang W; 2020;" exact="China" post="(27) 149 45.11 Â± 13.35 81 All COVID-19 patients"/>
 <result pre="were discharged and 76 remained in hospital. Young BE; 2020;" exact="Singapore" post="(28) 18 31 to 73 9 Symptomatic COVID-19 Lopinavir/ritonavir"/>
 <result pre="patients experienced side effects of antiviral therapy Zhang G; 2020;" exact="China" post="(29) 221 20 to 96 108 Non-severe and severe"/>
 <result pre="improved after administration of ECMO and IMV Zhou Z; 2020;" exact="China" post="(31) 10 29 to 68 8 Confirmed COVID-19 patients"/>
 <result pre="and 4 patients were discharged Case reports Han X; 2020;" exact="China" post="(14) 1 23 1 Diabetic patient with COVID-19 Oseltamivir/"/>
 <result pre="was discharged from hospital after 15 days Li W; 2020;" exact="China" post="(17) 5 10 months to 6 years 4 Children"/>
 <result pre="change the outcome or length of stay Lim J; 2020;" exact="South Korea" post="(18) 1 54 1 Symptomatic COVID-19 patient Lopinavir/ritonavir 1"/>
 <result pre="process or a result of anti-viral therapy Wang Z; 2020;" exact="China" post="(24) 4 19 to 63 3 COVID-19 patients Lopinavir/ritonavir"/>
 <result pre="recovered and 2 patients remained in hospital Zhang Z; 2020;" exact="China" post="(30) 2 38 1 Symptomatic COVID-19 patients oseltamivir and"/>
 <result pre="one clinical trial protocol commissioned by a research team in" exact="Saudi Arabia" post="existed. This study, named as the MIRACLE trial, was"/>
 <result pre="5ChenXChughtaiAADydaAMacIntyreCRComparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in" exact="Saudi Arabia" post="and South Korea Emerging microbes &amp;amp; infections20176116 6Alavi-MoghaddamMA Novel"/>
 <result pre="Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and" exact="South Korea" post="Emerging microbes &amp;amp; infections20176116 6Alavi-MoghaddamMA Novel Coronavirus (COVID-19) Outbreak"/>
 <result pre="virology2020[In press] 13GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical Characteristics of Coronavirus Disease 2019 in" exact="China" post="The New England journal of medicine2020 14HanXFanYWanYLShiHA Diabetic Patient"/>
 <result pre="infections with COVID-19 screened among close contacts in Nanjing, ChinaScience" exact="China" post="Life Sciences20201631564034 16HuangCWangYLiXRenLZhaoJHuYet al.Clinical features of patients infected with"/>
 <result pre="features of patients infected with 2019 novel coronavirus in Wuhan," exact="China" post="The Lancet202039510223497506 17LiWCuiHLiKFangYLiSChest computed tomography in children with COVID-19"/>
 <result pre="of 51 patients discharged from hospital with COVID-19 in Chongqing," exact="China" post="medRxiv2020[In press] 21QinXQiuSYuanYZongYTuoZLiJet al.Clinical Characteristics and Treatment of Patients"/>
 <result pre="Characteristics and Treatment of Patients Infected with COVID-19 in Shishou," exact="China" post="Lancet Respiratory Medicine2020Pre-Print. Available at SSRN: https://ssrn.com/abstract=3541147 22ShangJDuRLuQWuJXuSKeZet al.The"/>
 <result pre="138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan," exact="China" post="Jama20203231110619 24WangZChenXLuYChenFZhangWClinical characteristics and therapeutic procedure for four cases"/>
 <result pre="novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang," exact="China" post="The Journal of infection2020[In press] 28YoungBEOngSWXKalimuddinSLowJGTanSYLohJet al.Epidemiologic Features and"/>
 <result pre="Features and Clinical Course of Patients Infected With SARS-CoV-2 in" exact="Singapore" post="Jama2020[In press] 29ZhangGHuCLuoLFangFChenYLiJet al.Clinical features and outcomes of 221"/>
 <result pre="features and outcomes of 221 patients with COVID-19 in Wuhan," exact="China" post="medRxiv2020:Pre-Print. Available at MedRxiv: https://www.medrxiv.org/content/10.1101/2020.03.02.20030452v1 30ZhangZLiXZhangWShiZLZhengZWangTClinical Features and Treatment"/>
</results>
